CN101461841B - Chinese patent medicine for treating prostatoplasia - Google Patents
Chinese patent medicine for treating prostatoplasia Download PDFInfo
- Publication number
- CN101461841B CN101461841B CN2009100366407A CN200910036640A CN101461841B CN 101461841 B CN101461841 B CN 101461841B CN 2009100366407 A CN2009100366407 A CN 2009100366407A CN 200910036640 A CN200910036640 A CN 200910036640A CN 101461841 B CN101461841 B CN 101461841B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese patent
- patent medicine
- radix
- radix notoginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a Chinese patent drug for treating prostatoplasia. The Chinese patent drug comprises the following raw materials: 250 to 750 portions of pseudo-ginseng, 200 to 400 portions of Buthus martensi kirsch and 250 to 750 portions of kuh-seng. In the Chinese patent drug, the pseudo-ginseng has the functions of activating blood circulation and dissipating blood stasis, the Buthus martensi kirsch has the functions of detoxifying and resolving masses, and the kuh-seng has the function of clearing dampness and heat in liver and gallbladder and also has the diuretic effect, so that the Chinese patent drug can effect a radical cure on the prostatoplasia disease, avoid surgery, and relieve pain of patients.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine, particularly a kind of Chinese patent medicine for the treatment of prostatic hyperplasia.
Background technology
Prostatic hyperplasia be in, the commonly encountered diseases and the frequently-occurring disease of elderly men.According to many families statistics such as America and Europes, in elderly men, the prostatic hyperplasia sickness rate is up to more than 80%; Domesticly also reach more than 50%.In recent years, along with growth in the living standard, the development of Medical Technology, the average life of population also constantly prolongs, and this is the trend that rises gradually with regard to the sickness rate that has caused prostatic hyperplasia.Prostatic hyperplasia can cause the controlled micturition difficulty, and is not to the utmost dripping, and urine urgency-frequency, nocturia increase etc., further develop to cause urine retention, and renal insufficiency, complication such as serious urinary tract infection have a strong impact on quality of life of patient.Though operation is a treatment means the most completely, but most patients are worn with age, when treatment, must consider to block the whole body situation of degree simultaneously, especially whether the heart, lung, renal function can tolerate operation, the incidence rate of operation and complication is also higher once more simultaneously, for slight hypertrophy and older and can not tolerate surgery person, Drug therapy remains the important method of at first selecting.Yet the effect of Western medicine and Chinese patent medicine now is limited, is difficult to reach recovery from illness.
Summary of the invention
The technical problem to be solved in the present invention provides a kind of Chinese patent medicine for the treatment of prostatic hyperplasia, can effect a radical cure prostatic hyperplasia, needn't operative treatment.
In order to solve the problems of the technologies described above, a kind of Chinese patent medicine for the treatment of prostatic hyperplasia of the present invention, the raw material that described Chinese patent medicine is made is made of following component: 250~750 parts in Radix Notoginseng, 200~400 parts of Scorpios, 250~750 parts of Radix Sophorae Flavescentiss, 200~400 parts of Fructus Cnidiis, 200~400 parts of field dobbers, 200~500 parts of Herba Lysimachiaes, 200~500 parts in Talcum, 50~100 parts in Radix Glycyrrhizae, wherein, the manufacture method of described Chinese patent medicine is:
A) Scorpio, Radix Sophorae Flavescentis, Fructus Cnidii, field dobber, Herba Lysimachiae, Talcum and Radix Glycyrrhizae are mixed with water decocted 2 hours, extract decocting liquid for the first time, add decocting in the recrement again and boiled 1.5 hours, extract the decocting liquid second time;
B) first and second time decocting liquid is mixed, be concentrated into thick paste;
C) Radix Notoginseng is ground into the Radix Notoginseng fine powder, sieves;
D) step b gained thick paste is mixed with step c gained Radix Notoginseng fine powder, drying, final powder is broken into Powdered.
The invention has the beneficial effects as follows: Radix Notoginseng blood circulation promoting and blood stasis dispelling in this Chinese patent medicine, the Scorpio detoxicating and resolving stagnation of pathogens, the source is damp and hot on the Radix Sophorae Flavescentis liver heat removing gallbladder a diuresis in addition, and the disease that can effect a radical cure prostatic hyperplasia can be avoided operation, alleviates patient's misery.
The specific embodiment
A kind of Chinese patent medicine for the treatment of prostatic hyperplasia of the present invention, the raw material that described Chinese patent medicine is made comprises: 250~750 parts in Radix Notoginseng, 200~400 parts of Scorpios, 250~750 parts of Radix Sophorae Flavescentiss.
The raw material that described Chinese patent medicine is made also comprises: 200~400 parts of Fructus Cnidiis, 200~400 parts of field dobbers, 200~500 parts of Herba Lysimachiaes, 200~500 parts in Talcum, 50~100 parts in Radix Glycyrrhizae.
The manufacture method of described Chinese patent medicine is:
A) Scorpio, Radix Sophorae Flavescentis, Fructus Cnidii, field dobber, Herba Lysimachiae, Talcum and Radix Glycyrrhizae are mixed with water decocted 2 hours, extract decocting liquid for the first time, add decocting in the recrement again and boiled 1.5 hours, extract the decocting liquid second time;
B) first and second time decocting liquid is mixed, be concentrated into thick paste;
C) Radix Notoginseng is ground into the Radix Notoginseng fine powder, sieves;
D) step b gained thick paste is mixed with step c gained Radix Notoginseng fine powder, drying, final powder is broken into Powdered.
Above-mentioned finished medicines is added different adjuvants can be made into tablet, pill, capsule, electuary and oral liquid.Radix Notoginseng blood circulation promoting and blood stasis dispelling in this Chinese patent medicine, the Scorpio detoxicating and resolving stagnation of pathogens, the source is damp and hot on the Radix Sophorae Flavescentis liver heat removing gallbladder a diuresis in addition, be aided with Fructus Cnidii, field dobber in above-mentioned component, the effect of supporing yang the kidney invigorating can be arranged, Herba Lysimachiae, Talcum, Radix Glycyrrhizae have the effect of antiinflammatory diuretic, make the component of Chinese patent medicine more reasonable, can effect a radical cure the disease of prostatic hyperplasia, can avoid operation, alleviate patient's misery.Two application examples below are provided:
1. Wu, the man, 65 years old, on February 12nd, 2008 went to a doctor, and the patient began to occur frequent micturition, urgent micturition, nocturia increased frequency before 2 years.Once took Western medicine, Chinese patent drugs for treatment, but doing well,improving is not obvious.B ultrasonic shows prostate 5.0cm * 4.5cm, the rectal touch prostatauxe, and matter is harder, and disappearence of central groove has the tenderness sense.Take the each 2.5g medicated powder of this prescription and take after mixing it with water, every day three times, the urine condition improved is good after 10 days, and is normal fully after 20 days, does ultrasound diagnosis after continuing to take medicine 10 days, prostate 3.8cm * 3.5cm, and rectal touch prostate size is normal, quality deliquescing, no tenderness sense.
2. Zhang, 70 years old, on October 25th, 2007 examined.Sufferer is surplus with the conduit urethral catheterization moon, Western medicine, Chinese patent medicine therapeutic alliance therebetween, but do not feel any better, ultrasound diagnosis prostate 5.7cm * 4.8cm, the rectal touch prostatauxe, matter is harder, and disappearence of central groove has the tenderness sense.Take this prescription, every day three times, each 2.5g medicated powder is taken after mixing it with water.Urine compressing catheter is deviate from automatically after 15 days, and urine is normal after taking medicine 30 days, does ultrasound diagnosis after adding 10 days, prostate 4.0cm * 3.7cm, and rectal touch prostate size is normal, the quality deliquescing, no tenderness sense is followed the trail of and was not seen recurrence in 1 year.
Claims (1)
1. Chinese patent medicine for the treatment of prostatic hyperplasia, it is characterized in that the raw material that described Chinese patent medicine is made is made of following component: 250~750 parts in Radix Notoginseng, 200~400 parts of Scorpios, 250~750 parts of Radix Sophorae Flavescentiss, 200~400 parts of Fructus Cnidiis, 200~400 parts of field dobbers, 200~500 parts of Herba Lysimachiaes, 200~500 parts in Talcum, 50~100 parts in Radix Glycyrrhizae, wherein, the manufacture method of described Chinese patent medicine is:
A) Scorpio, Radix Sophorae Flavescentis, Fructus Cnidii, field dobber, Herba Lysimachiae, Talcum and Radix Glycyrrhizae are mixed with water decocted 2 hours, extract decocting liquid for the first time, add decocting in the recrement again and boiled 1.5 hours, extract the decocting liquid second time;
B) first and second time decocting liquid is mixed, be concentrated into thick paste;
C) Radix Notoginseng is ground into the Radix Notoginseng fine powder, sieves;
D) step b gained thick paste is mixed with step c gained Radix Notoginseng fine powder, drying, final powder is broken into Powdered.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100366407A CN101461841B (en) | 2009-01-09 | 2009-01-09 | Chinese patent medicine for treating prostatoplasia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100366407A CN101461841B (en) | 2009-01-09 | 2009-01-09 | Chinese patent medicine for treating prostatoplasia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101461841A CN101461841A (en) | 2009-06-24 |
CN101461841B true CN101461841B (en) | 2011-02-16 |
Family
ID=40802776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100366407A Expired - Fee Related CN101461841B (en) | 2009-01-09 | 2009-01-09 | Chinese patent medicine for treating prostatoplasia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101461841B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107362253A (en) * | 2017-06-20 | 2017-11-21 | 苏州市李良济健康产业有限公司 | A kind of preparation method for the health products for improving fecundity |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1294013A (en) * | 1999-10-26 | 2001-05-09 | 马俊杰 | Medicine for treating prostatic hyperplasia |
CN1682954A (en) * | 2005-03-14 | 2005-10-19 | 庹元斌 | Chinese medicine preparation for treating prostatic hyperplasia |
CN1961955A (en) * | 2006-11-15 | 2007-05-16 | 王信锁 | Chinese medicinal formulation for treating hyperplasia of prostate |
-
2009
- 2009-01-09 CN CN2009100366407A patent/CN101461841B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1294013A (en) * | 1999-10-26 | 2001-05-09 | 马俊杰 | Medicine for treating prostatic hyperplasia |
CN1682954A (en) * | 2005-03-14 | 2005-10-19 | 庹元斌 | Chinese medicine preparation for treating prostatic hyperplasia |
CN1961955A (en) * | 2006-11-15 | 2007-05-16 | 王信锁 | Chinese medicinal formulation for treating hyperplasia of prostate |
Also Published As
Publication number | Publication date |
---|---|
CN101461841A (en) | 2009-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100349594C (en) | Obstruction dredging wine | |
CN101406635B (en) | Chinese medicine decoction for treating stranguria and eliminating stone | |
CN101757566A (en) | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof | |
CN101862428B (en) | Chinese medicament for treating benign prostatic hyperplasia | |
CN102512630A (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
CN101732602B (en) | Medicament for treating calculi and preparation method thereof | |
CN101810823B (en) | Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine | |
CN104173782A (en) | Medicine treating urinary calculi | |
CN101461841B (en) | Chinese patent medicine for treating prostatoplasia | |
CN103083617A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
CN103393909B (en) | Chinese medicinal preparation for treating biliary calculus with cholecystitis | |
CN102335311A (en) | Decoction for treating intestinal obstruction, and application thereof | |
CN102000181A (en) | Chinese traditional medicine composition for treating diarrhea and method for preparing medicament from Chinese traditional medicine composition | |
CN102205002B (en) | Traditional Chinese medicine for treating intestinal cancer | |
CN101375965B (en) | Chinese medicine honeyed bolus for treating recurrent psoriasis in progressive stage | |
CN101259214A (en) | Medicine for treating hyperplasia of mammary glands | |
CN101411856A (en) | Medicament for treating osteoproliferation | |
CN103720949A (en) | Capsule for relieving constipation and clearing bowels and preparation method thereof | |
CN102698130A (en) | Traditional Chinese medicine extract for treating postoperative intestinal adhesion | |
CN101229281B (en) | Medicine for treating rheumatoid arthritis | |
CN101757137A (en) | Medication for treating mixed hemorrhoids and preparation method thereof | |
CN1850157B (en) | Health-care for resisting hyperplasia of mammary glands | |
CN105194526A (en) | Traditional Chinese medicine for treating hepatic calculi | |
CN101152300A (en) | Traditional Chinese medicine for treating stasis type intestinal obstruction | |
CN101703713B (en) | Chinese medicinal prescription for treating avascular necrosis of femoral head and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110216 Termination date: 20150109 |
|
EXPY | Termination of patent right or utility model |